Raising Capital in Life Sciences in 2022-2023: What Works?
By Greg Curhan
Raising money in the capital markets for a biopharma or life sciences company over the last few years has been quite a roller coaster ride. Funding among U.S. biotech startups reached a record high of $77 billion in 2021 (Crunchbase), as investors were attracted to expanding opportunities in genetics, therapeutics…Read MoreRead More
Fundraising Choices in Life Sciences: What, When & Why?
This article is the second in a two-part series about fundraising strategies for life science companies. In our last article, A Menu of Financing Alternatives for Life Science Companies, we looked at the continuum of choices available to life science companies who are actively engaged in fundraising to power up…Read MoreRead More